PRME
Biotechnology · Healthcare
Board Member, CEO
2025-05-19–present
Board Member
Prime Medicine, Inc. (PRME)Equibles does not estimate personal net worth.
Get an email with a short summary when Prime Medicine, Inc. publishes a filing, an earnings call transcript or a press release.
Get PRME alertsAllan Reine, M.D. is recorded as Board Member and CEO at Prime Medicine, Inc. (PRME) since May 19, 2025. Prime Medicine, Inc. reported in an 8-K filed May 19, 2025 that Allan Reine, M.D. was appointed Chief Executive Officer and principal executive officer, effective May 19, 2025. Prime Medicine, Inc. reported in an 8-K filed May 19, 2025 that Allan Reine, M.D. was appointed Class II director, effective May 19, 2025. Prime Medicine, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Prime Medicine, Inc. includes Allan Reine (CEO and Board Member), Jeffrey Marrazzo (Chairman), Svetlana Makhni (CFO) and 2 others.
“on May 16, 2025, the Board appointed Allan Reine, M.D., the Company’s Chief Financial Officer and principal financial officer, as Chief Executive Officer and principal executive officer of the Company, in addition to continuing in his current role as principal financial officer of the Company, in each case effective as of May 19, 2025.”
“The Board also appointed Dr. Reine to serve as a member of the Board as a Class II director to hold office until the Company’s annual meeting of stockholders to be held in 2027, until his successor is elected and qualified, or until his earlier death, resignation or removal, or until otherwise determined by the Board, effective as of May 19, 2025.”
2025-05-19–present
2025-05-19–present
PRME
Biotechnology · Healthcare
Board Member, CEO
2025-05-19–present